[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 2208 Introduced in Senate (IS)]

<DOC>






115th CONGRESS
  1st Session
                                S. 2208

    To provide for the issuance of an Alzheimer's Disease Research 
                           Semipostal Stamp.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            December 7, 2017

Mr. Markey (for himself, Ms. Collins, Mrs. Capito, and Mr. Van Hollen) 
introduced the following bill; which was read twice and referred to the 
        Committee on Homeland Security and Governmental Affairs

_______________________________________________________________________

                                 A BILL


 
    To provide for the issuance of an Alzheimer's Disease Research 
                           Semipostal Stamp.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALZHEIMER'S DISEASE RESEARCH SEMIPOSTAL STAMP.

    (a) Definition.--In this section, the term ``semipostal stamp'' has 
the meaning given the term ``semipostal'' in section 416(a)(1) of title 
39, United States Code.
    (b) Issuance.--In order to afford a convenient way for members of 
the public to contribute to funding for medical research relating to 
Alzheimer's disease, the United States Postal Service shall issue a 
semipostal stamp (referred to in this section as the ``Alzheimer's 
Disease Research Semipostal Stamp'') in accordance with subsection (c).
    (c) Terms and Conditions.--
            (1) In general.--Except as provided in this subsection, the 
        issuance and sale of the Alzheimer's Disease Research 
        Semipostal Stamp shall be governed by section 416 of title 39, 
        United States Code, and regulations issued under that section.
            (2) Duration.--The Alzheimer's Disease Research Semipostal 
        Stamp shall be made available to the public for a period of 6 
        years, beginning not later than 1 year after the date of 
        enactment of this Act.
            (3) Disposition of proceeds.--All amounts becoming 
        available from the sale of the Alzheimer's Disease Research 
        Semipostal Stamp (as determined under section 416(d) of title 
        39, United States Code) shall be transferred to the National 
        Institutes of Health, for the purpose described in subsection 
        (b), through payments which shall be made not less frequently 
        than 2 times a year.
            (4) Limitation.--For purposes of section 416 of title 39, 
        United States Code (including any regulation prescribed under 
        subsection (e)(1)(C) of that section), the semipostal stamp 
        issued under this section shall not apply to any limitation 
        relating to whether more than 1 semipostal stamp may be offered 
        for sale at the same time.
                                 <all>